SA
Sign upLog In

Madrigal Pharmaceuticals Inc (MDGL)

Cost of Revenue

$109.42M

TTM · Period ending: · USD

MDGL logo

MDGL Cost of Revenue

Latest reported$109.42M
MDGL TTM Cost of Revenue ($0.00 → $109.42M)
High-resolution chart · PNG

MDGL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Madrigal Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
109,424,000
78,482,000
56,148,000
35,145,000
19,175,000
10,746,000
6,233,000
2,788,000
636,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,000
56,000
84,000
109,000
105,000
101,000
96,000
131,000
116,000
100,000
77,000
17,000
8,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130,405,000
130,405,000
130,405,000
132,374,000
1,969,000
3,938,000
3,938,000
1,969,000
1,969,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.